RAAS Antagonism Reduces COVID-19 Severity in Obesity-Related Hypertension
Researchers investigated the effects of RAAS antagonism on the severity of COVID-19 in patients with obesity-related hypertension.
Researchers investigated the effects of RAAS antagonism on the severity of COVID-19 in patients with obesity-related hypertension.
Although some research has demonstrated that women with asthma may be at an increased risk for adverse outcomes during pregnancy, there may not be an increased risk for congenital malformations or pregnancy losses in these women.
In children being treated for acute asthma in emergency departments, the use of intravenous magnesium sulfate occurs late in the treatment regimen and in only a small percentage of patients.
Expression of the herpes virus entry mediator gene is associated with disease activity in patients with asthma and may, therefore, be a potential biomarker of asthma severity.
Incidence rates of severe asthma exacerbation are highest in children with severe asthma and a history of exacerbations.
Iron level in the airways may be closely related to the pathogenesis and severity of asthma.
A subset of patients with coronavirus disease 2019 (COVID-19) may present with low disease severity marked only by digestive symptoms.
Study results highlight that a risk scoring system would help prioritize high-risk individuals in primary care and emergency room settings for clinical care, isolation precautions and contact tracing efforts for people with COVID-19.
Hypoxemic respiratory failure and hypotension were the most common precursors of mortality in critically ill patients with COVID-19 during the first 3 weeks of the outbreak in Seattle, Washington.
In patients with asthma and eosinophilic chronic rhinosinusitis with nasal polyps, sinus surgery suppresses airway/systemic type 2 inflammation, therefore affecting asthma control.